Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Lek Pharmaceuticals aggregated by PharmaCompass.com.

    Client Virtual Booth

    LEK PHARMACEUTICALS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Lek Pharmaceuticals
    Slovenia Flag
    Country
    Country
    Slovenia
    Address
    Address
    Verovkova 57, 1526 Ljubljana
    Telephone
    Telephone
    +386 1 580 21 11
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://lek.si/en/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    China’s Porton to set up biotech park in Slovenia’s Menges
    China’s Porton to set up biotech park in Slovenia’s Menges

    https://intellinews.com/china-s-porton-to-set-up-biotech-park-in-slovenia-s-menges-266425/?source=slovenia

    INTELLINEWS
    10 Jan 2023
    Share Share
    Imbruvica® (Ibrutinib) : Pharmacyclics v. Zydus Worldwide DMCC
    Imbruvica® (Ibrutinib) : Pharmacyclics v. Zydus Worldwide DMCC

    https://www.pharmacompass.com/pdf/news/imbruvica-ibrutinib-pharmacyclics-v-zydus-worldwide-dmcc-1520247536.pdf

    PATENT LITIGATION
    16 Feb 2018
    Share Share
    Trintellix (Vortioxetine): H. Lundbeck v. Sandoz
    Trintellix (Vortioxetine): H. Lundbeck v. Sandoz

    https://www.pharmacompass.com/pdf/news/trintellix-vortioxetineh-lundbeck-v-sandoz-1517811354.pdf

    PATENT LITIGATION
    30 Jan 2018
    Share Share
    Sandoz's Lek Invests in Final Dosage Form Biosimilar Capabilities
    Sandoz's Lek Invests in Final Dosage Form Biosimilar Capabilities

    http://connect.dcat.org/blogs/pharma-news/2016/01/26/sandozs-lek-invests-in-final-dosage-form-biosimilar-capabilities#.Vqhfipp97IU

    DCAT CONNECT
    27 Jan 2016
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search